Korean J Urol Oncol.  2016 Aug;14(2):69-75. 10.22465/kjuo.2016.14.2.69.

Is the Expression of p53, c-erb-B2 and Ki-67 Influence the Prognosis of the Non-muscle Invasive Urothelial Bladder Cancer?

Affiliations
  • 1Department of Urology, School of Medicine, Catholic University of Daegu, Daegu, Korea. dykim@cu.ac.kr
  • 2Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Korea.
  • 3Department of Pathology, School of Medicine, Catholic University of Daegu, Daegu, Korea.

Abstract

PURPOSE
The immunohistochemial markers can be used to predict prognosis more accurately for several cancers. In non-muscle invasive urothelial carcinoma, p53, c-erb-B2 and Ki-67 are applicable. We investigated a retrospective analysis of the relation between the markers and clinical prognostic factors of urothelial bladder cancer.
MATERIALS AND METHODS
Data from 268 non-muscle invasive urothelial bladder cancer (Ta, T1) patients from one single center were collected. Immunohistochemical evaluation was carried out on 268 (p53, c-erb-B2, Ki-67) cases. Clinical prognostic factors are as follows; number of tumor, tumor invasiveness, tumor grade and recurrence. The sum of all positivity of 3 markers was made as a new factor and evaluation of correlation between this factor and prognostic factors was also done. Statistical analysis was done by chi-squares test and Pearson's correlation test.
RESULTS
Through chi-square test, there were significant relations between all markers and tumor invasiveness (p<0.001), tumor grade (p<0.001). Number of tumor is significantly related with Ki-67 (p=0.043). Recurrence is related with c-erb-B2 (p=0.010) and Ki-67 (p=0.043). There was also significant correlations between the sum of the markers and prognostic factors-tumor invasiveness (p<0,001), tumor grade (p<0.001) and recurrence (p=0.007).
CONCLUSIONS
In this study, evaluated markers were closely related with clinical prognostic factors and may contribute to decision making on risk-assessment and management strategy for non-muscle invasive urothelial bladder cancer.

Keyword

Urinary bladder neoplasms; Immunohistochemistry; Risk assessment

MeSH Terms

Decision Making
Humans
Immunohistochemistry
Prognosis*
Recurrence
Retrospective Studies
Risk Assessment
Urinary Bladder Neoplasms*
Urinary Bladder*
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr